Ethicon Transvaginal Mesh Lawsuits Move Forward, As Court Schedules Hearing On Preservation of Explanted Mesh, Bernstein Liebhard LLP Reports

The Firm is representing numerous women who allegedly suffered serious vaginal mesh complications, allegedly due to pelvic mesh products marketed by Ethicon, Inc. and other companies.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Free Case Review
We are representing numerous women who have allegedly suffered serious vaginal mesh complications due to Ethicon products. We are pleased to see the federal litigation moving forward.

New York, New York (PRWEB) May 30, 2014

Thousands of transvaginal mesh lawsuits (http://www.injurybeacon.com/transvaginal-mesh/lawsuit/) involving products manufactured by Ethicon, Inc. continue to move forward in the federal multidistrict litigation underway in U.S. District Court, Southern District of West Virginia. According to an Order issued on May 29th, the Court has scheduled a hearing on a Defense Motion Requiring Preservation of Explanted Mesh. The hearing will take place on June 13, 2014, at 10:00 a.m. in Huntington, West Virginia.

“We are representing numerous women who have allegedly suffered serious vaginal mesh complications due to Ethicon products. We are pleased to see the federal litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to investigate transvaginal mesh lawsuits on behalf of women who suffered serious complications, allegedly due to products marketed by Ethicon and other manufacturers.

Transvaginal Mesh Lawsuits
Court records indicate that nearly 18,000 claims have been filed against Ethicon in the Southern District of West Virginia, all of which allege the company’s pelvic mesh products caused recipients to suffer serious vaginal mesh complications, including chronic pain, mesh erosion, and organ damage. Plaintiffs further allege that the devices were defectively designed and inadequately tested, and that Ethicon did not provide doctors and patients with appropriate warnings regarding their risks. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee in the Ethicon proceeding.

According to court documents, Ethicon is just one of several defendants involved in vaginal mesh litigations in the Southern District of West Virginia, where more than 55,000 transvaginal mesh lawsuits have been filed. Mr. Grand is also serving on the Plaintiffs’ Steering Committees in proceedings involving: American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187).

Mr. Grand is also serving as Co-Liaison Counsel in two multicounty litigations underway in New Jersey Superior Court for transvaginal mesh lawsuits involving products marketed by C.R. Bard and Ethicon. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March with a jury awarding $11 million in compensatory and punitive damages to a woman who suffered vaginal mesh complications related to the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Women who allegedly suffered serious vaginal mesh complications following surgery to treat pelvic organ prolapse and stress urinary incontinence may be entitled to file their own vaginal mesh lawsuit. To learn more about the potential risks associated with transvaginal mesh, please visit Bernstein Liebhard LLP’s website, or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.injurybeacon.com
https://plus.google.com/115936073311125306742?rel=author